BIOIDENT Technologies Announces PhotonicLab Platform — Combines Printed Optoelectronics with Microfluidics; Enables Industry’s First Disposable, Lab-on-a-Chip Solutions for Mobile Chemical Analysis and In-Vitro Diagnostics
MENLO PARK, Calif.–(BUSINESS WIRE)–Sept. 18, 2006–BIOIDENT Technologies Inc., a leading company in the development of printed semiconductor-based photonic lab-on-a-chip solutions for life sciences, today announced the company’s PhotonicLab(TM) Platform. An industry first, the PhotonicLab Platform combines printed organic semiconductor-based optoelectronics with microfluidics to create a new class of disposable lab-on-a-chip systems, which enable mobile, real-time and multi-parameter detection of chemical and biological substances.
With BIOIDENT, end users have a cost-effective solution that eliminates the need for expensive, bulky readout systems. This results in significant cost savings and provides immediate test results on mobile devices, such as laptop computers, PDAs and smart phones. Now, by leveraging the latest in nanotechnology and materials science, the BIOIDENT Platform uses organic semiconductor-based technology to print light emitting and detecting capabilities directly on to any surface, including polymers and glass, enabling on-chip detection and analysis capabilities, thereby removing one of the biggest obstacles in the wide-spread adoption of microfluidic applications.
By combining printed optoelectronics with microfluidics — the science of formulating devices that deal with nanoliter or picoliter volumes of fluid — BIOIDENT can deliver lab-on-a-chip systems that can conduct multiple tests simultaneously and at the point of use for real-time analysis. These capabilities will enable new applications in analytics, bio/chemical defense and medical diagnostics markets. For example, water is commonly tested for chemical and biological contaminants. Today, tests are usually conducted with kits that are sent to labs, which takes time and can result in user error. With BIOIDENT technology, a single lab-on-a-chip can be developed to support multiple tests simultaneously and in-the-field, which reduces the potential for user error, increases testing efficiencies and reduces testing costs.
“BIOIDENT’s Platform is poised to revolutionize water and food analysis, chemical and biological agent detection and in-vitro diagnostics,” said Dr. Wasiq Bokhari, CEO for BIOIDENT. “Imagine: instead of waiting for days for water or blood test results from a lab, with BIOIDENT technology, we can have multi-parameter results immediately, at the point of use.”
About the BIOIDENT PhotonicLab Platform
As a subsidiary of NANOIDENT Technologies AG, the technology leader in the development and manufacture of organic semiconductor-based photonic solutions, BIOIDENT leverages NANOIDENT technology, which uses liquid conductive and semi-conductive materials to print optoelectronic circuits on almost any surface using inkjet printing. BIOIDENT’s PhotonicLab Platform combines printed organic photodetectors and OLEDs with microfluidics to create a new class of disposable lab-on-a-chip systems. Its features and benefits include:
— Mobile real-time detection of biological and chemical substances
— Simultaneous detection of multiple analytes in small form factors
— Disposable, application-specific and low-cost lab-on-a-chip devices
— Printed Reader-on-Chip(TM) technology that simplifies readout and usage, eliminating the need for traditional lab-on-a-chip reader technology
— Chip that provides digital interface to mobile devices, such as laptops, PDAs or smart phones. Application specific software can be downloaded via Internet
— Rapid productization cycle and ability to customize to user needs
Availability
BIOIDENT’s PhotonicLab Platform is available today directly from BIOIDENT for custom product development projects. BIOIDENT plans to work with industry partners for joint development of different applications based on the PhotonicLab Platform. The lab-on-a-chip solutions will be produced at NANOIDENT’s ORGANIC FAB. For more information about BIOIDENT and the PhotonicLab Platform, please visit www.bioident.com.
About BIOIDENT Technologies, Inc.
BIOIDENT is the technology leader in the development of printed semiconductor-based photonic lab-on-a-chip solutions for the life science market. The company’s core technology utilizes the latest breakthroughs in science and nanotechnology to create the BIOIDENT PhotonicLab(TM) Platform. The BIOIDENT Platform is used to produce the world’s first disposable photonic lab-on-a-chip solutions for next generation mobile analytics applications such as water and food analysis, chemical and biological agent detection, and personal or in-the-field diagnostics.
BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies AG. BIOIDENT is privately held with headquarters in Menlo Park, Calif. BIOIDENT leverages NANOIDENT’s Photonic Solutions Platform(TM) technology and its extremely fast manufacturing process, which uses liquid conductive and semi-conductive materials to print electronic circuits on almost any surface using an inkjet printer. For more information about BIOIDENT, please visit www.bioident.com.
